Opthea Ltd (OPT)

NASDAQ
7.730
+0.320(+4.32%)
  • Volume:
    23,758
  • Bid/Ask:
    6.500/7.720
  • Day's Range:
    7.645 - 7.880

OPT Overview

Prev. Close
7.41
Day's Range
7.645-7.88
Revenue
-
Open
7.75
52 wk Range
7.09-17.856
EPS
-
Volume
23,758
Market Cap
-
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
-
P/E Ratio
-
Beta
-
1-Year Change
-46.32%
Shares Outstanding
-
Next Earnings Date
Sep 01, 2021
What is your sentiment on Opthea Ltd?
or
Market is currently closed. Voting is open during market hours.

Opthea Ltd News

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesNeutralBuyBuySellSell
Technical IndicatorsSellSellStrong BuySellSell
SummaryNeutralNeutralStrong BuySellSell

Opthea Ltd Company Profile

Opthea Ltd Company Profile

Employees
0

Opthea Limited, a biotechnology company, develops and commercializes therapies primarily for eye disease in Australia. The company’s development activities are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors (VEGF) VEGF-C, VEGF-D, and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage. Its lead molecule is OPT-302, a soluble form of VEGFR-3 for the treatment of wet age-related macular degeneration and diabetic macular edema. The company was formerly known as Circadian Technologies Limited and changed its name to Opthea Limited in December 2015. Opthea Limited was incorporated in 1984 and is based in South Yarra, Australia.

Read More
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.